Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (63)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Daya, S.
Right arrow Articles by YoungLai, E. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daya, S.
Right arrow Articles by YoungLai, E. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 10, No. 7, pp. 1719-1724, 1995
© 1995 European Society of Human Reproduction and Embryology


research-article

Infertility: Natural cycles for in-vitro fertilization: cost-effectiveness analysis and factors influencing outcome*

Salim Daya1,2,3, Joanne Gunby1, Edward G. Hughes1, John A. Collins2,1, Margaret A. Sagle1 and Edward V. YoungLai1

1Departments of Obstetrics and Gynecology, McMaster University 1200 Main Street West, Hamilton, Ontario, L8N3Z5, Canada 2Clinical Epidemiology and Biostatistics, McMaster University 1200 Main Street West, Hamilton, Ontario, L8N3Z5, Canada

Correspondence: 3To whom correspondence should be addressed at the Department of Obstetrics and Gynecology

Improvements in oocyte culture technique, sperm preparation, oocyte retrieval method and ovarian stimulation regimens have produced higher pregnancy rates with in-vitro fertilization (IVF) treatment. However, because ovarian stimulation is expensive and not without risk, there is increasing interest in the option of using natural cycles for IVF. This study was performed to document the experience and outcome in 240 natural cycles. Cancellation occurred in 28 cycles (12%), and LH surge was observed in 56 (23%), leaving 156 (65%) cycles which progressed to oocyte retrieval. No oocytes were retrieved in 26 cycles. Among the successful oocyte retrievals, the majority yielded one oocyte. There was no evidence of fertilization in 26 cases, and triploid fertilization was observed in 12 cases. Embryos suitable for transfer were available in 92 cycles in which 11 (12%) clinical pregnancies were confirmed. Despite the high failure rate at each step in the process, natural cycles are more cost-effective than stimulated cycles which incur an incremental cost per live birth of $48 000. Natural cycles offer a low-cost alternative that may be more accessible to patients.

Key words: cost-effectiveness/in-vitro fertilization/natural cycles/outcomes/unstimulated cycles

*Presented at the 14th meeting of the International Federation of Gynecology and Obstetrics in Montreal, Quebec, Canada, September 7–10, 1994.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
M.F.G. Verberg, N.S. Macklon, G. Nargund, R. Frydman, P. Devroey, F.J. Broekmans, and B.C.J.M. Fauser
Mild ovarian stimulation for IVF
Hum. Reprod. Update, January 1, 2009; 15(1): 13 - 29.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
W. Ombelet, I. Cooke, S. Dyer, G. Serour, and P. Devroey
Infertility and the provision of infertility medical services in developing countries
Hum. Reprod. Update, November 1, 2008; 14(6): 605 - 621.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.J. Pelinck, N.E.A. Vogel, A. Hoek, A.H.M. Simons, E.G.J.M. Arts, M.H. Mochtar, S. Beemsterboer, M.N. Hondelink, and M.J. Heineman
Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study
Hum. Reprod., September 1, 2006; 21(9): 2375 - 2383.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.J. Pelinck, N.E.A. Vogel, A. Hoek, E.G.J.M. Arts, A.H.M. Simons, and M.J. Heineman
Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study
Hum. Reprod., March 1, 2005; 20(3): 642 - 648.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Garceau, J. Henderson, L.J. Davis, S. Petrou, L.R. Henderson, E. McVeigh, D.H. Barlow, and L.L. Davidson
Economic implications of assisted reproductive techniques: a systematic review
Hum. Reprod., December 1, 2002; 17(12): 3090 - 3109.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.K. Omland, P. Fedorcsak, R. Storeng, P.O. Dale, T. Abyholm, and T. Tanbo
Different aetiological mechanisms for unexplained and endometriosis-associated infertility cannot be inferred from unstimulated IVF cycles using HCG to induce ovulation
Hum. Reprod., July 1, 2002; 17(7): 1927 - 1927.
[Full Text]


Home page
Hum ReprodHome page
A.K. Omland, P. Fedorcsak, R. Storeng, P.O. Dale, T. Abyholm, and T. Tanbo
Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility
Hum. Reprod., December 1, 2001; 16(12): 2587 - 2592.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E.R. Hernandez
Avoiding multiple pregnancies: sailing uncharted seas
Hum. Reprod., April 1, 2001; 16(4): 615 - 616.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. J. Ingerslev, A. Hojgaard, J. Hindkjar, and U. Kesmodel
A randomized study comparing IVF in the unstimulated cycle with IVF following clomiphene citrate
Hum. Reprod., April 1, 2001; 16(4): 696 - 702.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Nargund, J. Waterstone, J.M. Bland, Z. Philips, J. Parsons, and S. Campbell
Cumulative conception and live birth rates in natural (unstimulated) IVF cycles
Hum. Reprod., February 1, 2001; 16(2): 259 - 262.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Cil, I. S. Tummon, A. A. House, B. Taylor, G. Hooker, J. Franklin, R. Rankin, and M. Carey
A tale of two syndromes: ovarian hyperstimulation and abdominal compartment: Case report
Hum. Reprod., May 1, 2000; 15(5): 1058 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R.M.J. Janssens, C.B. Lambalk, J.P.W. Vermeiden, R. Schats, and J. Schoemaker
In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic
Hum. Reprod., February 1, 2000; 15(2): 314 - 318.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Gerris, D. De Neubourg, K. Mangelschots, E. Van Royen, M. Van de Meerssche, and M. Valkenburg
Prevention of twin pregnancy after in-vitro fertilization or intracytoplasmic sperm injection based on strict embryo criteria: a prospective randomized clinical trial
Hum. Reprod., October 1, 1999; 14(10): 2581 - 2587.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Bassil, P.A. Godin, and J. Donnez
Outcome of in-vitro fertilization through natural cycles in poor responders
Hum. Reprod., May 1, 1999; 14(5): 1262 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L.G. Mantovani, A. Belisari, and T.D. Szucs
Pharmaco-economic aspects of in-vitro fertilization in Italy
Hum. Reprod., April 1, 1999; 14(4): 953 - 958.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Rongieres-Bertrand, F. Olivennes, C. Righini, R. Fanchin, J. Taieb, S. Hamamah, P. Bouchard, and R. Frydman
Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation
Hum. Reprod., March 1, 1999; 14(3): 683 - 688.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.